Cargando…

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.

Veno-occlusive disease (VOD) of the liver is a clinical syndrome characterized by hyperbilirubinemia, painful hepatomegaly, and fluid retention. In the bone marrow transplantation (BMT) setting, VOD is caused by dose-intensive chemotherapy and/or radiotherapy used to prepare patients for transplant....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, J. H., Lee, K. H., Choi, J. S., Zang, D. Y., Kim, S. B., Kim, S. W., Suh, C., Lee, J. S., Kim, W. K., Lee, Y. S., Kim, S. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Academy of Medical Sciences 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053940/ https://www.ncbi.nlm.nih.gov/pubmed/8835758

Ejemplares similares

PB2472: HOSPITAL BURDEN OF VENO-OCCLUSIVE DISEASE (VOD): COMPARISON OF HOSPITAL STAYS WITH VOD PRINCIPAL VERSUS SECONDARY DIAGNOSIS
por: Aggarwal, Saurabh, et al.
Publicado: (2023)

Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019)

Publisher Correction: Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019)

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study
por: Forrest, D L, et al.
Publicado: (2003)

PB2337: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH VENO-OCCLUSIVE DISEASE (VOD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
por: Aggarwal, S., et al.
Publicado: (2022)

P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY
por: Mohty, M., et al.
Publicado: (2022)

Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
por: Bonifazi, Francesca, et al.
Publicado: (2020)

P1354: A SYSTEMATIC LITERATURE REVIEW (SLR) OF THE MANIFESTATIONS OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN ADULTS VERSUS CHILDREN
por: Angus, J., et al.
Publicado: (2022)

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation
por: Shin, Seung-Hwan, et al.
Publicado: (2013)

Increased expression of urokinase type plasminogen activator(u-PA), plasminogen activator inhibitor-1(PAI-1), and collagenases in Caco-2 cells infected by Salmonella typhimurium.
por: Park, C. G., et al.
Publicado: (1997)

PB2470: VENO-OCCLUSIVE DISEASE (VOD)/SINUSOIDAL OBSTRUCTION SYNDROME (SOS) INCIDENCE AND TREATMENT TRENDS INSIGHTS FROM LATEST SYSTEMATIC REVIEW OF CASE REPORTS (2018-2023)
por: Aggarwal, Saurabh, et al.
Publicado: (2023)

PB1875: NON-HEMATOPOIETIC CELL TRANSPLANT-RELATED VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) IN SOLID TUMOR AND HEMATOLOGIC MALIGNANCIES: A SYSTEMATIC REVIEW
por: Stewart, Fiona, et al.
Publicado: (2023)

Allogeneic BMT in ATL: whom to transplant and which modality to use
por: Kannagi, Mari
Publicado: (2014)

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model
por: Crumrine, R Christian, et al.
Publicado: (2011)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
por: Kong, Seom Gim, et al.
Publicado: (2022)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

BWDAT: A research tool for analyzing the consumption of VOD content at home
por: Cordeiro, José A., et al.
Publicado: (2020)

Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation
por: Yeom, Mi Young, et al.
Publicado: (2015)

Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)
por: Dyer, Gemma, et al.
Publicado: (2016)

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.
por: Hong, S. I., et al.
Publicado: (1996)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Prognostic factors of acute myelocytic leukemia: an analysis of 132 patients in a single institution.
por: Lee, K. H., et al.
Publicado: (1996)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial
por: Chowdary, Pratima, et al.
Publicado: (2023)

A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
por: Shirazy, Mohamed, et al.
Publicado: (2019)

uPA-mediated plasminogen activation is enhanced by polyphosphate
por: Whyte, Claire S., et al.
Publicado: (2020)

Mitomycin induced pulmonary veno-occlusive disease
por: Kunadu, Afua, et al.
Publicado: (2021)

Phase 2, randomized, open-label study on catheter-directed thrombolysis with plasmin versus rtPA and placebo in acute peripheral arterial occlusion
por: Comerota, Anthony J., et al.
Publicado: (2019)

Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors
por: Berger, C, et al.
Publicado: (1999)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
por: Shibata, Soichiro, et al.
Publicado: (2022)

Defibrotide for hepatic veno-occlusive disease
Publicado: (2021)

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
por: Kinoshita, Hannah, et al.
Publicado: (2022)

Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis
por: Park, In-Serk, et al.
Publicado: (2008)

Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202
por: Lai, Tsung-Po, et al.
Publicado: (2022)

Call for case histories of BMT in patients with coincident schizophrenia
por: Sommer, I E, et al.
Publicado: (2013)

Call for case histories of BMT in patients with coincident schizophrenia
por: Sommer, I E, et al.
Publicado: (2013)

Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR.
por: Kim, Y. S., et al.
Publicado: (1999)

A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke
por: Yang, Jie, et al.
Publicado: (2016)

Detection of Aspergillus by Nested Assay in Bone Marrow Transplantation (BMT) Patients
por: Teifoori, F, et al.
Publicado: (2011)

Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kghvdp32f4er9q883l140nlp62